Fundamental changes in regulation to improve access to biosimilars
Bulletin of the World Health Organization · 01.07.2026 · 104 (7) · 517-521
DOI: 10.2471/blt.25.294908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of the World Health Organization, online erschienen am 01.07.2026. Verfasst von Hye-Na Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicines and Health Products Policies and Standards Department, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Medicines and Health Products Policies and Standards Department, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
- Biotherapeutics and Advanced Therapies, R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, England.
Förderung
- World Health Organization
Zitieren
APA
Kang, H. N., Knezevic, I., Wadhwa, M., & Kim, E. K. (2026). Fundamental changes in regulation to improve access to biosimilars. Bulletin of the World Health Organization, 104(7), 517-521. https://doi.org/10.2471/blt.25.294908
Vancouver
Kang HN, Knezevic I, Wadhwa M, Kim EK. Fundamental changes in regulation to improve access to biosimilars. Bulletin of the World Health Organization. 2026;104(7):517-521. doi:10.2471/blt.25.294908
BibTeX
@article{Kang2026,
author = {Kang, Hye-Na and Knezevic, Ivana and Wadhwa, Meenu and Kim, Eun Kyung},
title = {Fundamental changes in regulation to improve access to biosimilars},
journal = {Bulletin of the World Health Organization},
year = {2026},
volume = {104},
number = {7},
pages = {517--521},
doi = {10.2471/blt.25.294908}
}
EUVIMED